Search - Institut Bergonié Access content directly

Filter your results

59 Results
Deposit type : Notice

Premature Ovarian Failure and Fertility in Long-Term Survivors of Hodgkin's Lymphoma: A European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Étude des Lymphomes de l'Adulte Cohort Study

Marleen A.E. van Der Kaaij , Natacha Heutte , Paul Meijnders , Edwige Abeilard-Lemoisson , Michele Spina , et al.
Journal of Clinical Oncology, 2012, 30 (3), pp.291-299. ⟨10.1200/JCO.2011.37.1989⟩
Journal articles hal-02358987v1

[Non-surgical treatment modalities available for the treatment of upper tract urothelial carcinomas: state-of-the-art for the yearly scientific report of the French National Association of Urology]

François Audenet , Morgane Roupret , Nadine Houédé , Pierre Colin
Progrès en Urologie, 2014, 24, pp.1030--40. ⟨10.1016/j.purol.2014.07.002⟩
Journal articles hal-02168056v1

A phase II trial evaluating the efficacy and safety of efavirenz in metastatic castration-resistant prostate cancer

Nadine Houédé , M. Pulido , L. Mourey , F. Joly , J. M. Ferrero , et al.
Oncologist, 2014, 19, pp.1227--8. ⟨10.1634/theoncologist.2014-0345⟩
Journal articles hal-02168062v1

Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial

Patricia Pautier , Anne Floquet , Christine Chevreau , Nicolas Penel , Cécile Guillemet , et al.
Lancet Oncology, 2015, 16 (4), pp.457-464. ⟨10.1016/s1470-2045(15)70070-7⟩
Journal articles hal-03623745v1

Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study

H. Bonnefoi , W. Jacot , M. Saghatchian , C. Moldovan , L. Venat-Bouvet , et al.
Annals of Oncology, 2015, 26 (2), pp.325-332. ⟨10.1093/annonc/mdu551⟩
Journal articles hal-02277402v1

Non sentinel node involvement prediction for sentinel node micrometastases in breast cancer: nomogram validation and comparison with other models.

Gilles Houvenaeghel , Marie Bannier , Claude Nos , Sylvia Giard , Hervé Mignotte , et al.
Breast, 2012, 21 (2), pp.204-209. ⟨10.1016/j.breast.2011.09.013⟩
Journal articles hal-00760573v1

Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)

Franck Bonnetain , Bert Bonsing , Thierry Conroy , Adelaide Dousseau , Bengt Glimelius , et al.
European Journal of Cancer, 2014, 50 (17), pp.2983 - 2993. ⟨10.1016/j.ejca.2014.07.011⟩
Journal articles hal-01802621v1

Stimulation of the Human RAD51 Nucleofilament Restricts HIV-1 Integration In Vitro and in Infected Cells

O. Cosnefroy , A. Tocco , P. Lesbats , S. Thierry , C. Calmels , et al.
Journal of Virology, 2011, 86 (1), pp.513-526. ⟨10.1128/jvi.05425-11⟩
Journal articles hal-03065212v1

CD95L cell surface cleavage triggers a pro-metastatic signaling pathway in triple negative breast cancer.

Marine Malleter , Sebastien Tauzin , Alban Bessede , Remy Castellano , Armelle Goubard , et al.
Cancer Research, 2013, 73 (22), pp.6711-21. ⟨10.1158/0008-5472.CAN-13-1794⟩
Journal articles hal-00873634v1

Pure tubular carcinoma of the breast and sentinel lymph node biopsy: a retrospective multi-institutional study of 234 cases.

Magali Dejode , Christine Sagan , Loïc Campion , Gilles Houvenaeghel , Sylvia Giard , et al.
EJSO - European Journal of Surgical Oncology, 2013, 39 (3), pp.248-254. ⟨10.1016/j.ejso.2012.12.009⟩
Journal articles hal-00913914v1

Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old

Eva Comperat , Stéphane Larré , Morgan Rouprêt , Yann Neuzillet , Géraldine Pignot , et al.
Virchows Archiv, 2015, 466 (5), pp.589 - 594. ⟨10.1007/s00428-015-1739-2⟩
Journal articles hal-01936408v1

Dynamic Modeling of Electroporation for the Computation of the Electric Field Distribution Inside Biological Tissues during the Application of the Pulse Voltage

Lluis Mir , Clair Poignard , Riccardo Scorretti , A. Silve , Damien Voyer
1rst World Congress of Electroporation, WC2015, Sep 2015, Portorož, Slovenia. pp.211-214, ⟨10.1007/978-981-287-817-5_47⟩
Conference papers hal-01285366v1

Role of Pro-oncogenic Protein Disulfide Isomerase (PDI) Family Member Anterior Gradient 2 (AGR2) in the Control of Endoplasmic Reticulum Homeostasis

Arisa Higa , Audrey Mulot , Frederic Delom , Marion Bouchecareilh , Duc Thang Nguyên , et al.
Journal of Biological Chemistry, 2011, 286 (52), pp.44855-44868. ⟨10.1074/jbc.M111.275529⟩
Journal articles hal-02400392v1

Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial

E. Munzone , A. Giobbie-Hurder , B. Gusterson , E. Mallon , G. Viale , et al.
Annals of Oncology, 2015, 26 (12), pp.2442-2449. ⟨10.1093/annonc/mdv391⟩
Journal articles hal-02337334v1

Dynamic contrast enhanced MRI-derived parameters are potential biomarkers of therapeutic response in bladder carcinoma

Camille Chakiba , Francois Cornelis , Edouard Descat , Marine Gross-Goupil , Paul Sargos , et al.
European Journal of Radiology, 2015, 84 (6), pp.1023 - 1028. ⟨10.1016/j.ejrad.2015.02.026⟩
Journal articles hal-01934927v1

Polymorphisms in SLCO1B3 and NR1I2 as genetic determinants of hematotoxicity of carboplatin and paclitaxel combination

Litaty Céphanoée Mbatchi , Antonin Schmitt , Fabienne Thomas , Yoann Cazaubon , Jacques Robert , et al.
Pharmacogenomics, 2015, 16 (13), pp.1439 - 1450. ⟨10.2217/pgs.15.84⟩
Journal articles hal-01913499v1

Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial

K. Fizazi , G. Gravis , Aude Flechon , L. Geoffrois , C. Chevreau , et al.
Annals of Oncology, 2014, 25, pp.987--91. ⟨10.1093/annonc/mdu099⟩
Journal articles hal-02168058v1

A phase Ib trial of LY2584702 tosylate, a p70 S6 inhibitor, in combination with erlotinib or everolimus in patients with solid tumours

A. Hollebecque , Nadine Houédé , E. E. Cohen , C. Massard , A. Italiano , et al.
European Journal of Cancer, 2014, 50, pp.876--84. ⟨10.1016/j.ejca.2013.12.006⟩
Journal articles hal-02168061v1

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.

Valérie Bonadona , Bernard Bonaïti , Sylviane Olschwang , Sophie Grandjouan , Laetitia Huiart , et al.
Journal of the American Medical Association, 2011, 305 (22), pp.2304-2310. ⟨10.1001/jama.2011.743⟩
Journal articles hal-00780536v1

A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trials

Adélaide Doussau , Rodolphe Thiebaut , B. Geoerger , Patrick Schoffski , Anne Floquet , et al.
Annals of Oncology, 2015, 26 (2), pp.422-428. ⟨10.1093/annonc/mdu523⟩
Journal articles hal-01288869v1

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors.

Nicolas F Delahaye , Sylvie Rusakiewicz , Isabelle Martins , Cédric Ménard , Stephan Roux , et al.
Nature Medicine, 2011, 17 (6), pp.700-7. ⟨10.1038/nm.2366⟩
Journal articles hal-00665651v1

Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas

Antoine Italiano , Angela Cioffi , Nicolas Penel , Matteo Giaj Levra , Corinne Delcambre , et al.
Cancer, 2012, 118 (13), pp.3330-3336. ⟨10.1002/cncr.26599⟩
Journal articles hal-03623788v1

Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial†

E. Deutsch , C. Lemanski , J.-P. Pignon , A. Levy , A. Delarochefordiere , et al.
Annals of Oncology, 2013, 24 (11), pp.2834 - 2838. ⟨10.1093/annonc/mdt368⟩
Journal articles hal-01798389v1

Apports de la radiothérapie avec modulation d'intensité guidée par l'image dans les cancers prostatiques. [Benefit of intensity modulated and image-guided radiotherapy in prostate cancer.]

I. Latorzeff , J. Mazurier , C. Boutry , P. Dudouet , P. Richaud , et al.
21e Congrès national de la Société Française de Radiothérapie Oncologique (SFRO), Oct 2010, Paris, France. pp.479-487, ⟨10.1016/j.canrad.2010.06.013⟩
Conference papers istex hal-00909914v1

Randomized, placebo-controlled, phase III trial of sunitinib plus prednisone versus prednisone alone in progressive, metastatic, castration-resistant prostate cancer

Y. C. Ou , L. Sengelov , F. Saad , Nadine Houédé , P. Ostler , et al.
Journal of Clinical Oncology, 2014, 32, pp.76--82. ⟨10.1200/JCO.2012.48.5268⟩
Journal articles hal-02168067v1

Characterization of prostate neuroendocrine cancers and therapeutic management: a literature review

P. Sargos , L. Ferretti , M. Gross-Goupil , M. Orre , F. Cornelis , et al.
Prostate Cancer and Prostatic Diseases, 2014, 17, pp.220--6. ⟨10.1038/pcan.2014.17⟩
Journal articles hal-02168068v1

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial.

Aurore Blesius , Philippe A Cassier , François Bertucci , Jérome Fayette , Isabelle Ray-Coquard , et al.
BMC Cancer, 2011, 11, pp.72. ⟨10.1186/1471-2407-11-72⟩
Journal articles hal-00779604v1

Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU)

Jean-Léon Lagrange , Gilles Créhange , Olivier Chapet , Renaud De Crevoisier , David Azria , et al.
Cancer Treatment Reviews, 2015, 41 (10), pp.814-820. ⟨10.1016/j.ctrv.2015.10.005⟩
Journal articles hal-01260598v1

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)

Sophie Gourgou-Bourgade , D. Cameron , P. Poortmans , B. Asselain , D. Azria , et al.
Annals of Oncology, 2015, 26 (5), pp.873-879. ⟨10.1093/annonc/mdv106⟩
Journal articles hal-02284722v1

Long-term follow-up of patients with papillary and follicular thyroid cancer : a prospective study on 715 patients.

M. Brassard , I. Borget , A. Edet-Sanson , A.-L. Giraudet , O. Mundler , et al.
Journal of Clinical Endocrinology and Metabolism, 2011, 96 (5), pp.1352-1359
Journal articles hal-00942209v1